A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE - Lap Colectomy)
Latest Information Update: 05 Jul 2021
At a glance
- Drugs Bupivacaine (Primary) ; Ketorolac; Morphine; Nonsteroidal anti-inflammatories
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms IMPROVE-Lap Colectomy
- Sponsors Pacira BioSciences
- 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).
- 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).
- 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).